[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Shionogi & Co. Ltd. Shionogi & Co. Ltd. is seeing high social engagement with positive sentiment around AI in drug development and COVID-19 research. The company is also submitting a supplemental new drug application for Ensitrelvir in Japan for COVID-19 in pediatric patients. ### About Shionogi & Co. Ltd. Shionogi & Co. Ltd. is a Japanese pharmaceutical company. ### Insights [#](/topic/$4507t/insights) - Shionogi & Co. Ltd. creators is up XXXXXX% from the previous X months. - Shionogi & Co. Ltd. mentions is up XXXXX% from the previous week. - Shionogi & Co. Ltd. posts created is up XXXXXX% from the previous X months. ### Price: $ [#](/topic/$4507t/close) ---  [Price 24-Hour Chart Data](/topic/$4507t/time-series/close.tsv) The price volatility is likely due to a combination of high social engagement, positive sentiment around AI in drug development and COVID-19 research, alongside potential uncertainties related to clinical trials and market cap. **1-Year High**: $XXXXX on 2025-06-30 **1-Year Low**: $XXXXX on 2024-11-20 ### AltRank: undefined [#](/topic/$4507t/alt_rank) ---  [AltRank 24-Hour Chart Data](/topic/$4507t/time-series/alt_rank.tsv) Shionogi & Co. Ltd. is currently AltRank #undefined based on combined combined social and market metrics **Daily Average**: XXXXX **1-Year High**: XXXXX on 2024-11-21 **1-Year Low**: XXX on 2024-12-28 ### Galaxy Score: XX [#](/topic/$4507t/galaxy_score) ---  [Galaxy Score 24-Hour Chart Data](/topic/$4507t/time-series/galaxy_score.tsv) **Current Value**: XX **Daily Average**: XX **1-Year High**: XX on 2025-03-03 **1-Year Low**: XX on 2024-11-02 ### Engagements: XXX [#](/topic/$4507t/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$4507t/time-series/interactions.tsv) **Current Value**: XXX **Daily Average**: XXXXXXX **1 Week**: XXXXX -XX% **1 Month**: XXXXXXX +582% **6 Months**: XXXXXXXXX -XX% **1 Year**: XXXXXXXXXX +5,808% **1-Year High**: XXXXXXXXX on 2025-01-01 **1-Year Low**: X on 2024-08-05 | Social Network | X | Reddit | YouTube | TikTok | | -------------- | - | ------ | ------- | ------ | | Engagements | XXX | XX | X | XXX | ### Mentions: XX [#](/topic/$4507t/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$4507t/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XX **1 Week**: XXX +22% **1 Month**: XXX +16% **6 Months**: XXX +376% **1 Year**: XXX +245% **1-Year High**: XXX on 2025-07-10 **1-Year Low**: X on 2024-07-27 | Social Network | X | Reddit | YouTube | TikTok | | -------------- | - | ------ | ------- | ------ | | Mentions | XX | XX | XX | X | ### Creators: XX [#](/topic/$4507t/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$4507t/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Shionogi & Co. Ltd. in the last XX hours which is down XX% from XX in the previous XX hours **Daily Average**: XX **1 Week**: XX +13% **1 Month**: XXX +13% **6 Months**: XXX +332% **1 Year**: XXX +171% **1-Year High**: XX on 2025-07-10 **1-Year Low**: X on 2024-07-27 ### Sentiment: XX% [#](/topic/$4507t/sentiment) ---  [Sentiment 24-Hour Chart Data](/topic/$4507t/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XX% -XX% **1 Month**: XX% -XX% **6 Months**: XX% -XX% **1 Year**: XX% -XX% **1-Year High**: XXX% on 2024-07-24 **1-Year Low**: XX% on 2025-01-24 **Most Supportive Themes** - **AI in Drug Development:** (60%) Social posts highlight the positive impact of AI in drug development, improving efficiency and reducing clinical trial times. - **PrEP for COVID-19:** (30%) The social community is responding positively to Shionogi's developments in preventative measures for respiratory diseases, specifically for COVID-19. **Most Critical Themes** - **Clinical Trial Concerns:** (0.1%) Social posts express concerns about clinical trial methodologies. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XX | X% | XXX | XX% | X | X% | | Reddit | XX | X% | X | X% | X | X% | | YouTube | X | X% | X | X% | X | X% | | TikTok | XXX | XX% | XX | XX% | X | X% | | | | | | | | | | Total | XXX | XX% | XXX | XX% | X | X% | ### Market Cap: $undefined [#](/topic/$4507t/market_cap) ---  [Market Cap 24-Hour Chart Data](/topic/$4507t/time-series/market_cap.tsv) **Current Value**: $undefined **Daily Average**: $XXXXXXXXXXXXXXXXX **1-Year High**: $XXXXXXXXXXXXXXXXX on 2024-08-12 **1-Year Low**: $XXXXXXXXXXXXXXXXX on 2024-08-05 **Top assets mentioned** In the posts about Shionogi & Co. Ltd. in the last XX hours [Pfizer, Inc. (PFE)](/topic/$pfe) [Alphabet Inc Class A (GOOGL)](/topic/$googl) [Innovative Solutions & Support (ISSC)](/topic/$issc) [Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences) **Top topics mentioned** In the posts about Shionogi & Co. Ltd. in the last XX hours [japan](/topic/japan), [coins music](/topic/coins-music), [stocks](/topic/stocks), [coins healthcare](/topic/coins-healthcare), [approved](/topic/approved), [$pfe](/topic/$pfe), [stocks healthcare](/topic/stocks-healthcare), [investment](/topic/investment), [kenya](/topic/kenya), [$googl](/topic/$googl), [stocks communication services](/topic/stocks-communication-services), [fuji](/topic/fuji), [taiwan](/topic/taiwan), [singapore](/topic/singapore), [pacific](/topic/pacific), [australia](/topic/australia), [tokyo](/topic/tokyo), [india](/topic/india), [help the](/topic/help-the), [bloomberg](/topic/bloomberg), [radar](/topic/radar), [wsj](/topic/wsj), [nct](/topic/nct), [op](/topic/op), [shin](/topic/shin), [fxs](/topic/fxs), [korea](/topic/korea), [south korea](/topic/south-korea), [$issc](/topic/$issc), [women](/topic/women), [mother of](/topic/mother-of), [$4188t](/topic/$4188t), [$8058t](/topic/$8058t), [$8306t](/topic/$8306t), [mitsubishi](/topic/mitsubishi), [united states](/topic/united-states), [$4523t](/topic/$4523t), [$6417t](/topic/$6417t), [$4568t](/topic/$4568t), [china](/topic/china), [$1177hk](/topic/$1177hk), [$4901t](/topic/$4901t), [$2269t](/topic/$2269t), [sustainability](/topic/sustainability), [$600m](/topic/$600m), [drugs](/topic/drugs), [gilead sciences](/topic/gilead-sciences) ### Top Social Posts [#](/topic/$4507t/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "See how Shionogi developed a system with SAS Viya to semi-automate clinical trials without compromising safety efficacy or compliance. #AIinHealthcare #ClinicalTrials" [@sasindia](/creator/x/sasindia) on [X](/post/tweet/1947146304225763773) 2025-07-21 04:07:09 UTC 1504 followers, XX engagements "Submission of Letter of Intent and Concept Note to the Kenyan Ministry of Health to Accelerate Access to Cefiderocol #Cefiderocol #Fetroja #Fetcroja #AMR #Antibiotics #GlobalHealth #Shionogi #GARDP #AccessToMedicines #Kenya #Stewardship #GramNegative #PharmaForGood #InfectiousDiseases #HealthcareAccess #AntimicrobialResistanceChatGPT" [@stellanewslife](/creator/x/stellanewslife) on [X](/post/tweet/1946642234797146430) 2025-07-19 18:44:10 UTC XXX followers, XX engagements "Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan #Shionogi #CorporateGovernance #RestrictedStock #ExecutiveCompensation #ESG #LongTermIncentives #JapanPharma #BoardResolution #TreasuryShares #GovernanceReform" [@stellanewslife](/creator/x/stellanewslife) on [X](/post/tweet/1946642019625165131) 2025-07-19 18:43:18 UTC XXX followers, XX engagements "Conclusion of Investment Agreement with Japan Hydrogen Fund L.P. #Shionogi #HydrogenEconomy #Sustainability #Decarbonization #JapanHydrogenFund #ESGinvestment #ClimateAction #JH2A #GreenFuture #PharmaESG" [@stellanewslife](/creator/x/stellanewslife) on [X](/post/tweet/1946641811071742158) 2025-07-19 18:42:29 UTC XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Shionogi & Co. Ltd. is seeing high social engagement with positive sentiment around AI in drug development and COVID-19 research. The company is also submitting a supplemental new drug application for Ensitrelvir in Japan for COVID-19 in pediatric patients.
Shionogi & Co. Ltd. is a Japanese pharmaceutical company.
Price 24-Hour Chart Data
The price volatility is likely due to a combination of high social engagement, positive sentiment around AI in drug development and COVID-19 research, alongside potential uncertainties related to clinical trials and market cap.
1-Year High: $XXXXX on 2025-06-30
1-Year Low: $XXXXX on 2024-11-20
AltRank 24-Hour Chart Data
Shionogi & Co. Ltd. is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXXXX
1-Year High: XXXXX on 2024-11-21
1-Year Low: XXX on 2024-12-28
Galaxy Score 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2024-11-02
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXXX +582%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXXX +5,808%
1-Year High: XXXXXXXXX on 2025-01-01
1-Year Low: X on 2024-08-05
Social Network | X | YouTube | TikTok | |
---|---|---|---|---|
Engagements | XXX | XX | X | XXX |
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX +22%
1 Month: XXX +16%
6 Months: XXX +376%
1 Year: XXX +245%
1-Year High: XXX on 2025-07-10
1-Year Low: X on 2024-07-27
Social Network | X | YouTube | TikTok | |
---|---|---|---|---|
Mentions | XX | XX | XX | X |
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Shionogi & Co. Ltd. in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX +13%
1 Month: XXX +13%
6 Months: XXX +332%
1 Year: XXX +171%
1-Year High: XX on 2025-07-10
1-Year Low: X on 2024-07-27
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -XX%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-07-24
1-Year Low: XX% on 2025-01-24
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XX | X% | XXX | XX% | X | X% |
XX | X% | X | X% | X | X% | |
YouTube | X | X% | X | X% | X | X% |
TikTok | XXX | XX% | XX | XX% | X | X% |
Total | XXX | XX% | XXX | XX% | X | X% |
Market Cap 24-Hour Chart Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXXXX on 2024-08-12
1-Year Low: $XXXXXXXXXXXXXXXXX on 2024-08-05
Top assets mentioned In the posts about Shionogi & Co. Ltd. in the last XX hours
Pfizer, Inc. (PFE) Alphabet Inc Class A (GOOGL) Innovative Solutions & Support (ISSC) Gilead Sciences, Inc. (GILD)
Top topics mentioned In the posts about Shionogi & Co. Ltd. in the last XX hours
japan, coins music, stocks, coins healthcare, approved, $pfe, stocks healthcare, investment, kenya, $googl, stocks communication services, fuji, taiwan, singapore, pacific, australia, tokyo, india, help the, bloomberg, radar, wsj, nct, op, shin, fxs, korea, south korea, $issc, women, mother of, $4188t, $8058t, $8306t, mitsubishi, united states, $4523t, $6417t, $4568t, china, $1177hk, $4901t, $2269t, sustainability, $600m, drugs, gilead sciences
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"See how Shionogi developed a system with SAS Viya to semi-automate clinical trials without compromising safety efficacy or compliance. #AIinHealthcare #ClinicalTrials"
@sasindia on X 2025-07-21 04:07:09 UTC 1504 followers, XX engagements
"Submission of Letter of Intent and Concept Note to the Kenyan Ministry of Health to Accelerate Access to Cefiderocol #Cefiderocol #Fetroja #Fetcroja #AMR #Antibiotics #GlobalHealth #Shionogi #GARDP #AccessToMedicines #Kenya #Stewardship #GramNegative #PharmaForGood #InfectiousDiseases #HealthcareAccess #AntimicrobialResistanceChatGPT"
@stellanewslife on X 2025-07-19 18:44:10 UTC XXX followers, XX engagements
"Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan #Shionogi #CorporateGovernance #RestrictedStock #ExecutiveCompensation #ESG #LongTermIncentives #JapanPharma #BoardResolution #TreasuryShares #GovernanceReform"
@stellanewslife on X 2025-07-19 18:43:18 UTC XXX followers, XX engagements
"Conclusion of Investment Agreement with Japan Hydrogen Fund L.P. #Shionogi #HydrogenEconomy #Sustainability #Decarbonization #JapanHydrogenFund #ESGinvestment #ClimateAction #JH2A #GreenFuture #PharmaESG"
@stellanewslife on X 2025-07-19 18:42:29 UTC XXX followers, XX engagements
/topic/$4507t